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Goodpaster (2020) has presented a
convincing case for a role of specific
subcellular species of ceramides and
diacylglycerols in the development
of insulin resistance (IR). Indeed, a
2016 Journal of Physiology CrossTalk
by our opponent presented a similarly
eloquent argument for ceramides
based on pharmacological, genetic
and cross-sectional studies (Summers
& Goodpaster, 2016). We refer readers
to the 2016 CrossTalk for a robust
opposing view, but would like to add
that more recent research has confirmed
that pharmacological interventions,
e.g. myriocin, have off-site effects, and
might even improve insulin sensitivity
independently of ceramides (Pillon et al.
2018; Appriou et al. 2019). The 2016
opposing view also overlooked that the
insulin sensitising effect of pharmacological
and gene knockout models that lower lipid
is usually restricted to the liver, whereas
skeletal muscle remains largely unaffected
(Holland et al. 2007; Li et al. 2011). Thus,
whereas we wholeheartedly agree that
intramuscular lipid is often associated with
IR, we still contend that clear causation has
not been demonstrated by the arguments
presented (Goodpaster, 2020).
It can be tempting to infer causation
from this large body of associative
data (Goodpaster, 2020); however, the
demonstration of a clear disassociation
between intramuscular lipid accumulation
and IR refutes a causal relationship.
Specifically, as outlined in our initial
argument, we and others have demonstrated
that physical inactivity rapidly leads to IR,
and often in the absence of changes in
specific ceramide species implicated in IR
(e.g. C16:0 and C18:0; Dirks et al. 2016).
Crucially, none of the human intervention
studies in our opponent’s proposal have
accounted for habitual physical activity.
Moreover, all of the human studies
referenced were cross-sectional in nature or
used physical activity to improve peripheral
IR, and we are unaware of any time-course
studies in humans that have the temporality
to delineate changes in IR from lipid
accumulation. Of course, it could be argued
that physical inactivity causes a physio-
logical decline in muscle glucose uptake,
and that intramuscular lipid-induced IR
is pathophysiological. However, given that
physical inactivity has been implicated in
epidemiological studies and randomized
controlled trials as a major cause for IR
independently of obesity (Lee et al. 2012),
and eventually leads to intramuscular lipid
accumulation, we cannot rule out that intra-
muscular lipids are innocent bystanders and
that there is no ‘athlete’s paradox’. Clearly,
well-controlled time-course studies directly
targeting specific lipid species are required
to support the paradigm that intramuscular
lipids per se (and exclusively) cause IR.
Call for comments
Readers are invited to give their views on this
and the accompanying CrossTalk articles in
this issue by submitting a brief (250 word)
comment. Comments may be submitted up
to 6 weeks after publication of the article, at
which point the discussion will close and the
CrossTalk authors will be invited to submit
a ‘Last Word’. Please email your comment,
including a title and a declaration of inter-
est, to jphysiol@physoc.org. Comments will
be moderated and accepted comments will
be published online only as ‘supporting
information’ to the original debate articles
once discussion has closed.
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